IBio (IBIO) on Friday filed a preliminary prospectus for the sale of up to around 11.3 million shares of its common stock by certain selling stockholders.
The shares are issuable upon the exercise of warrants sold to the selling stockholders in a private placement completed on April 30, the company said.
The warrants have an exercise price of $0.86 per share and will expire five years after issuance, iBio said.
The company said that it will not receive any of the proceeds from the sale of the shares, but will receive approximately $9.7 million in cash if the warrants are exercised in full. This will be used for working capital and general corporate purposes, the company added.
Shares of iBio were down 5.8% in recent trading Friday.
Price: 0.97, Change: -0.06, Percent Change: -5.83
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.